
Taiwan Main Orthopaedic Biotechnology/Surglasses achieved a milestone with the completion of the first augmented reality (AR) surgery in the United States using its Caduceus S AR Spine Navigation System.
Caduceus S requires minimal C-arm images to equip surgeons with augmented reality (AR) and pre-surgical planning with trajectories for spine surgery.
Caduceus S is designed to allow surgeons to superimpose 3D spinal anatomy on a patient during surgical procedures. It is equipped with multiple trackers and displays preoperatively planned trajectories via a 3D AR head-mounted display.
The system received FDA 510(k) marketing clearance in late 2022.
Taiwan Main Orthopaedic Biotechnology/Surglasses achieved a milestone with the completion of the first augmented reality (AR) surgery in the United States using its Caduceus S AR Spine Navigation System.
Caduceus S requires minimal C-arm images to equip surgeons with augmented reality (AR) and pre-surgical planning with trajectories for spine...
Taiwan Main Orthopaedic Biotechnology/Surglasses achieved a milestone with the completion of the first augmented reality (AR) surgery in the United States using its Caduceus S AR Spine Navigation System.
Caduceus S requires minimal C-arm images to equip surgeons with augmented reality (AR) and pre-surgical planning with trajectories for spine surgery.
Caduceus S is designed to allow surgeons to superimpose 3D spinal anatomy on a patient during surgical procedures. It is equipped with multiple trackers and displays preoperatively planned trajectories via a 3D AR head-mounted display.
The system received FDA 510(k) marketing clearance in late 2022.
Source: Taiwan Main Orthopaedic Biotechnology Co., Ltd.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





